Long-term Procedural and Device Related Complications of PFO Closure

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06413147

Enrollment

100

Registered

2024-05-14

Start date

2024-05-30

Completion date

2029-05-30

Last updated

2024-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patent Foramen Ovale

Brief summary

We aimed to explore: (1）long-term complications of PFO closure; (2) antiplate or anticoagulation use after PFO closure.

Interventions

DEVICEPFO closure

Surgery of PFO closure

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Inclusion criteria

* All patients who underwent PFO closure

Exclusion criteria

* Unable to complete or adhere to the study

Design outcomes

Primary

Measure	Time frame
ischemic stroke, Hemorrhagic stroke or transient ischemic attack	1 month, 6 months, 1 year, 3 years, 5 years

Secondary

Measure	Time frame
death	1 month, 6 months, 1 year, 3 years, 5 years
open-heart surgery	1 month, 6 months, 1 year, 3 years, 5 years
residual leaks	1 month, 6 months, 1 year, 3 years, 5 years
atrial fibrillation	1 month, 6 months, 1 year, 3 years, 5 years
Hemorrhage related to the use of antithrombotic drugs	1 month, 6 months, 1 year, 3 years, 5 years
Other severe events related to PFO closure	1 month, 6 months, 1 year, 3 years, 5 years

Contacts

Primary ContactChunlin Yin

yinclmail@163.com13552566227

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026